Manufacturing

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Articles

Industry wants more innovation, but can suppliers meet customer needs?

Biomanufacturing Innovation

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Critical issues that should be considered when scaling up a hot-melt extrusion process.

Scale-up Challenges in Hot-Melt Extrusion

Modular factory concepts, which take flexible manufacturing to the next level, are beginning to take hold in the biopharmaceutical industry.

Modular Factory Concept Gains Traction

Amy Ritter was Scientific Editor, BioPharm International.

On Mar. 7, 2012, GE Healthcare announced an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, for an undisclosed amount.

GE Healthcare to Acquire Xcellerex

Angie Drakulich was editorial director of Pharmaceutical Technology.

The standardization of upstream and downstream bioprocessing is growing, but several kinks need to be ironed out.

Platform Technologies

In a world where product recalls can mean the end of a company, all batches must be perfect.

Total Recall

Debottlenecking downstream mAb purification.

Single-Use High Capacity Membrane Chromatography

Experts discuss solutions for filter bacterial retention and related challenges. Contains online bonus material.

Optimizing Adjuvant Filtration: A Technical Forum

Jerold Martin was the senior vice president of global scientific affairs at Pall Life Sciences and the chairman of the Board and Technology Committee at Bio-Process Systems Alliance.

This column will address some of the questions on how single use systems are sterilized by gamma irradiation and what documentation may be requested by regulators.

Equipment